Antimicrobial Resistance and Quest for Novel Antibiotics in Asia
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 3612
Special Issue Editors
Interests: antimicrobial resistance; antibiotics; gut microbiome systematics; natural product chemistry
Interests: antimicrobial resistance; bacteriophage; endolysin; molecular microbiology
Interests: soil, water and sediment; organic pollutants; trace elements; mercury; VOCs; arctic sediment; remediation; bacteria; isolation and screening of microorganisms; gene sequencing; bioremediation; chemical oxidation
Special Issue Information
Dear Colleagues,
The rise and dissemination of resistant bacteria and the improper use of antibiotics have led to increasing cases of antimicrobial resistance. The rise and spread of antimicrobial resistance can threaten public health and add an economic burden. Insufficient surveillance systems, a lack of appropriate policy, and poor publications regarding the use of antibiotics and its resistance pattern have complicated the exact scenario of antimicrobial resistance. Consequently, the search for novel alternatives of antibiotics is inevitable. In recent years, several effective strategies have been introduced to discover novel antibiotics from uncultured microorganisms, in addition to phage therapy and endolysin as alternatives of antibiotics. This Special Issue includes studies regarding antimicrobial resistance in Asia, with the aim of discovering novel antibiotics from uncultured microbes, bacteriophage, and endolysins.
Dr. Ram Hari Dahal
Dr. Md. Maidul Islam
Dr. Dhiraj Kumar Chaudhary
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- multidrug-resistant pathogens
- uncultured bacteria
- novel antibiotics
- bacteriophage
- endolysin
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
